GGrantIndex
← Leaderboards

Kenneth L Koch

Pennsylvania State Univ Hershey Med Ctr

$6,267,419
Attributed
$6,267,419
Total exposure
6
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $835.6K · FY200622
$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$6,267,419 · 6

By mechanism

U01$6,081,679 · 1
M01$185,740 · 5

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Gastroparesis

Research focus

GastroparesisSymptomsResponseNauseaStomachGastric EmptyingDatabasesEnrollmentClinical ResearchPhysiologicalFunctional DisorderUnited States National Institutes Of HealthNeuromuscularRegistriesSatiationBaseDyspepsiaChronicWaterMotility DisorderCell MotilityQuestionnairesInsightHyperglycemia

Grant awards (27)

Exploration of Subtypes of Gastroparesis and Gastroparesis-like Symptoms based on Physiological Testing$387,500
U01 · FY2022 · DK · contact PI
Subtypes of Gastroparesis$387,500
U01 · FY2020 · DK · contact PI
Subtypes of Gastroparesis$108,259
U01 · FY2020 · DK · contact PI
Subtypes of Gastroparesis$387,500
U01 · FY2019 · DK · contact PI
Subtypes of Gastroparesis$387,500
U01 · FY2018 · DK · contact PI
Subtypes of Gastroparesis$387,500
U01 · FY2017 · DK · contact PI
Subtypes of Gastroparesis$387,500
U01 · FY2016 · DK · contact PI
Gastroparesis Consortium Continuation and New Type 2 Diabetes Mellitus Studiies$303,091
U01 · FY2015 · DK · contact PI
Gastroparesis Consortium Continuation and New Type 2 Diabetes Mellitus Studiies$303,091
U01 · FY2014 · DK · contact PI
Gastroparesis Consortium Continuation and New Type 2 Diabetes Mellitus Studiies$302,382
U01 · FY2013 · DK · contact PI
Gastroparesis Consortium Continuation and New Type 2 Diabetes Mellitus Studiies$303,091
U01 · FY2012 · DK · contact PI
Gastroparesis Consortium Continuation and New Type 2 Diabetes Mellitus Studiies$361,912
U01 · FY2011 · DK · contact PI
Gastroparesis, Gastric Dysrhythmias, and Dyspepsia Symptoms in Type 2 Diabetes$285,970
U01 · FY2010 · DK · contact PI
GASTROPARESIS REGISTRY$87,696
M01 · FY2010 · RR · contact PI
CLINICAL TRIAL: NORIG$1,731
M01 · FY2010 · RR · contact PI
Gastroparesis, Gastric Dysrhythmias, and Dyspepsia Symptoms in Type 2 Diabetes$343,831
U01 · FY2009 · DK · contact PI
Gastroparesis, Gastric Dysrhythmias, and Dyspepsia Symptoms in Type 2 Diabetes$270,188
U01 · FY2009 · DK · contact PI
Gastroparesis, Gastric Dysrhythmias, and Dyspepsia Symptoms in Type 2 Diabetes$150,000
U01 · FY2009 · DK · contact PI
GASTROPARESIS REGISTRY$71,539
M01 · FY2009 · RR · contact PI
Gastroparesis, Gastric Dysrhythmias, and Dyspepsia Symptoms in Type 2 Diabetes$332,103
U01 · FY2008 · DK · contact PI
GASTROPARESIS REGISTRY$24,774
M01 · FY2008 · RR · contact PI
Gastroparesis, Gastric Dysrhythmias, and Dyspepsia Symptoms in Type 2 Diabetes$334,732
U01 · FY2007 · DK · contact PI
Gastroparesis Gastric Dysrhythmias and Dyspepsia Symp*$9,750
U01 · FY2007 · DK · contact PI
Gastroparesis, Gastric Dysrhythmias, Dyspepsia in T2DM$348,279
U01 · FY2006 · DK · contact PI
NK1 ANTAGONIST GR205171 &IN COMBINATION W ONDANSETRON$0
M01 · FY2002 · RR
NK1 ANTAGONIST GR205171 &IN COMBINATION W ONDANSETRON$0
M01 · FY2001 · RR
NK1 ANTAGONIST GR205171 &IN COMBINATION W ONDANSETRON$0
M01 · FY2000 · RR